Investor Hub
Latest quarterly earnings
Latest investor presentation
Annual report
Latest publications
Pipeline
NASDAQ:NVAX
NASDAQ:NVAX
Latest quarterly earnings
Latest investor presentation
Annual report
Latest publications
Pipeline
Latest press releasesEvents & presentationsReports & financialsSEC filingsStock details & analyst coverage
Press releases & statements
Aug 28, 2026
COVID-19,Corporate and finance
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
Latest press releases
Events & presentationsReports & financialsSEC filingsStock details & analyst coverage
Press releases & statements
Aug 28, 2026
COVID-19,Corporate and finance
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
Corporate governance
IR
contact
contact
Phone
(844) 668-2829
Email
Get notifications for investor updates
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings and more.
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.
